In this interview, we discuss a mathematical model that was created to predict patient response to immunotherapy for cancer treatment.
Matthew D. Hellmann, MD
Advertisement
Articles by Matthew D. Hellmann, MD
Advertisement
Latest Updated Articles
Predicting Response to Immunotherapy With a Mathematical ModelPublished: December 23rd 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Regorafenib/Nivolumab Exhibits Nonsuperior Survival in Gastric Cancer
2
Pembrolizumab Combo Significantly Improves PFS/OS in Recurrent PROC
3
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
4
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
5
